Cargando…
Biologic response modifiers in gynecologic malignancies.
Biological therapy is currently being investigated in the treatment of a number of malignancies. The hypothesis for the use of this therapeutic modality involves an attempt to stimulate an already existent but perhaps suboptimal immune response to foreign protein, including tumor. Immunologic therap...
Autores principales: | Dutcher, J. P., Wadler, S., Wiernik, P. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590271/ https://www.ncbi.nlm.nih.gov/pubmed/2461003 |
Ejemplares similares
-
Long-Term Response and Possible Cure of Patients With B-Cell Malignancies With Dose-Escalated Rituximab
por: Jacobs, Lauren M., et al.
Publicado: (2017) -
Pure Red Cell Aplasia Following Interleukin-2 Therapy
por: Dutcher, Janice P., et al.
Publicado: (2016) -
An ontogenetic approach to gynecologic malignancies
por: Santiago, Inês A., et al.
Publicado: (2016) -
Editorial: Harnessing DNA Damage Response in Gynecologic Malignancies
por: Tse, Ka Yu, et al.
Publicado: (2022) -
The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013)